ICKSMCB 2021 / 2021 International Conference of the Korean Society for Molecular and Cellular Biology / November 3 - 5, 2021 / ICC JEJU

Plenary Lectures

HOME > Program > Plenary Lectures

Plenary Lecture ¥° November 3 (Wed), 15:00-15:50, Tamna Hall A

Elain_Fuchs

Tissue Stem Cells: Coping With Stress

Elaine Fuchs, Ph.D.
 
Rockefeller University, USA
Organizer & Chair: Hanseul Yang, Ph.D. (Korea Advanced Institute of Science and Technology (KAIST), Korea)



Elaine Fuchs is renowned for her research in skin biology, its stem cells and associated genetic disorders, particularly cancers. She studies how stem cells make and repair tissues and how they withstand stress from wounds, mechanical trauma, inflammation and cancer-causing mutations. Following her Ph.D. from Princeton and postdoctorate at MIT, Fuchs joined the faculty at University of Chicago. In 2002, she relocated to The Rockefeller University, where she is an Investigator of the Howard Hughes Medical Institute and Rebecca C. Lancefield Professor of Mammalian Cell Biology and Development. Fuchs has published >350 peer-reviewed manuscripts, and trained >30 Ph.D. students and 100 postdoctoral fellows. Fuchs’ awards and honors include the National Medal of Science, L’Oreal-UNESCO Award, Albany Prize in Medicine, March of Dimes Prize, International Pezcoller Award in Cancer Research, EB Wilson Award in Cell Biology, Vanderbilt Prize, AACR Clowes Award, ISSCR McEwen Award for Innovation in Stem Cell Research, and the Gairdner International Award. Fuchs is an honorary member of the National Academy of Sciences, National Academy of Medicine, American Philosophical Society, Pontifical Academy of Sciences and the Royal Society. Her honorary doctorates include Harvard University. She is past-President of the American Society of Cell Biology and the International Society of Stem Cell Research. She serves on the Board of Trustees of Cold Spring Harbor Laboratories, Board of Directors of the Damon Runyon Cancer Foundation, Scientific Advisory Boards of many international and national Universities and the Editorial Boards of major scientific journals. Fuchs is a tireless supporter of women scientists.

Plenary Lecture ¥± November 4 (Thu), 11:50 -12:40, Tamna Hall A

Medzhitov

Tissue Homeostasis and Inflammation

Ruslan Medzhitov, Ph.D.
Yale University School of Medicine, USA
Organizer & Chair: Jun Young Hong, Ph.D. (Yonsei University, Korea)



Ruslan Medzhitov obtained his undergraduate degree from Tashkent State University in 1990 and his doctoral degree from Moscow State University in 1993. Medzhitov joined the faculty of the Department of Immunobiology at Yale University School of Medicine in 1999. He is currently a Sterling Professor of Immunobiology at Yale University School of Medicine and is an Investigator of the Howard Hughes Medical Institute. Research Interests: Biology of inflammation, host pathogen interactions, mechanisms of autoimmunity and allergy. Medzhitov is a member of the National Academy of Sciences, National Academy of Medicine, and European Molecular Biology Organization, he is a fellow of the American Academy of Microbiology and a foreign member of the Russian Academy of Sciences.

Plenary Lecture ¥² November 4 (Thu), 18:10 -19:10, Tamna Hall A

kyuyoung_go

Organ-specific Vascular Heterogeneity

Gou Young Koh, M.D., Ph.D.
Korea Advanced Institute of Science and Technology (KAIST)
Center for Vascular Research, Institute for Basic Science, Korea
Organizer & Chair: Narry Kim, Ph.D. (Seoul National University & Institute for Basic Science, Korea)


Gou Young Koh is a distinguished professor at KAIST Graduate School of Medical Science and Engineering, and the director of Center for Vascular Research, Institute for Basic Science. He is also an external member of Max-Plank Institute. For last 25 years, he and his research team have focused on discovery and understanding of the growth factors regulating micro-vasculatures including tumor vasculature. During this time, his research team has made numerous major advances and breakthroughs in the field of angiogenesis and lymphangiogenesis. Notably, he and his research team discovered and generated several novel and potent modulators of angiogenesis - three angiopoietin-like proteins, COMP-Ang1, DAAP, Valpha and ABTAA - based on their keen observations and creative ideas. Moreover, he and his team have made ground-breaking discoveries in understanding of the unique features and regulations of tumor vessel normalization and their related changes in tumor microenvironment, metabolism and immunity, as well as on the characterization of key factors involved in the organotypic angiogenesis and vascular maintenance. Lately, they have performed landmark studies in uncovering of critical regulators for maintaining integrity of specialized lymphatic vessels such as Schlemm¡¯s canal, lacteals, and meningeal lymphatic vessels. He is currently focusing on understanding roles of surrounding stromal cells in vascular communications. By recognition of his outstanding and excellent achievements and contributions to biomedical communities, he became laureates of Kyung-Am Prize (2011), Asan Award in Medicine (2012) and Ho-Am Prize in Medicine (2018).

Plenary Lecture ¥³ November 5 (Fri), 11:50 -12:40, Tamna Hall A

Joseph Takahashi

Circulating Tumor Cells: a Window into Cancer Metastasis

Daniel A. Haber, M.D.,Ph.D.
Harvard Medical School, USA
Organizer & Chair : Hyun Woo Park, Ph.D. (Yonsei University, Korea)


Dr. Daniel Haber is Director of the Massachusetts General Hospital (MGH) Cancer Center and the Kurt Isselbacher Professor of Oncology at Harvard Medical School (HMS). He received his MD/PhD from Stanford in 1983, completed an internal medicine residency at MGH, clinical oncology training at Dana-Farber Cancer Institute (DFCI), and a postdoctoral research fellowship at MIT. He joined the faculty of HMS in 1991. Dr. Haber¡¯s numerous awards include a MERIT Award from the National Cancer Institute, a Dream Team Award from the Prostate Cancer Foundation and a Dream Team Award from Stand-Up-To-Cancer, and the Richard and Linda Rosenthal Memorial Award from the American Association for Cancer Research (AACR). He was appointed to the Howard Hughes Medical Institute in 2008, and he was elected to the Institute of Medicine in 2009, the American Academy of Arts and Sciences in 2011, and the National Academy of Sciences in 2018. Dr. Haber¡¯s research has focused primarily in the field of cancer genetics, resulting in discoveries on the origin of the pediatric kidney cancer Wilms tumor, genetic predispositions to breast cancer, and mutations that define a subset of ¡°nonsmoker¡± lung cancers that are uniquely sensitive to targeted new therapies. In collaboration with MGH bioengineer Dr. Mehmet Toner, Dr. Haber¡¯s laboratory has developed a novel technology for isolating rare circulating tumor cells (CTCs) from the blood of cancer patients - a tool that may have profound implications for early diagnosis of cancer and for non-invasive molecular profiling of cancers during therapy.